3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine

C155H134N48O10 — CID 158428423

About 3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine

3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine (PubChem CID 158428423) has the molecular formula C155H134N48O10 and a molecular weight of 2829.10 g/mol. Its IUPAC name is 3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine.

Molecular Properties

• Compound Name: 3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine
• PubChem CID: 158428423
• Molecular Formula: C155H134N48O10
• Molecular Weight: 2829.10 g/mol
• Exact Mass: 2827.15
• IUPAC Name: 3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine
• SMILES: CC(NC(=O)c1nc2ccccc2nc1N)c1ccccc1.CN(C)c1cccc(CNC(=O)c2nc3ccccc3nc2N)c1.Cc1ccc(-c2nnc(-c3nc4ccccc4nc3N)o2)cc1.Cc1cccc(CNC(=O)c2nc3ccccc3nc2N)c1.Cc1cccc(CNC(=O)c2nc3ccccc3nc2N)c1.Cc1nnc(-c2nc3ccccc3nc2N)o1.Cc1nnc(-c2nc3ccccc3nc2N)o1.Nc1ccccc1-c1nnc(-c2nc3ccccc3nc2N)o1.Nc1nc2ccccc2nc1-c1nnc(-c2cccnc2)o1.Nc1nc2ccccc2nc1C(=O)NCc1ccccc1
• InChI: InChI=1S/C18H19N5O.C17H13N5O.3C17H16N4O.C16H12N6O.C16H14N4O.C15H10N6O.2C11H9N5O/c1-23(2)13-7-5-6-12(10-13)11-20-18(24)16-17(19)22-15-9-4-3-8-14(15)21-16;1-10-6-8-11(9-7-10)16-21-22-17(23-16)14-15(18)20-13-5-3-2-4-12(13)19-14;2*1-11-5-4-6-12(9-11)10-19-17(22)15-16(18)21-14-8-3-2-7-13(14)20-15;1-11(12-7-3-2-4-8-12)19-17(22)15-16(18)21-14-10-6-5-9-13(14)20-15;17-10-6-2-1-5-9(10)15-21-22-16(23-15)13-14(18)20-12-8-4-3-7-11(12)19-13;17-15-14(19-12-8-4-5-9-13(12)20-15)16(21)18-10-11-6-2-1-3-7-11;16-13-12(18-10-5-1-2-6-11(10)19-13)15-21-20-14(22-15)9-4-3-7-17-8-9;2*1-6-15-16-11(17-6)9-10(12)14-8-5-3-2-4-7(8)13-9/h3-10H,11H2,1-2H3,(H2,19,22)(H,20,24);2-9H,1H3,(H2,18,20);2*2-9H,10H2,1H3,(H2,18,21)(H,19,22);2-11H,1H3,(H2,18,21)(H,19,22);1-8H,17H2,(H2,18,20);1-9H,10H2,(H2,17,20)(H,18,21);1-8H,(H2,16,19);2*2-5H,1H3,(H2,12,14)
• InChIKey: HBIPZWPVLIKFGT-UHFFFAOYSA-N
• XLogP: 23.17
• TPSA: 900.25 Ų
• H-Bond Donors: 16
• H-Bond Acceptors: 53
• Rotatable Bonds: 24
• Heavy Atoms: 213
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2829.10
LogP ≤ 5	23.17
H-Bond Donors ≤ 5	16
H-Bond Acceptors ≤ 10	53

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'aniline', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine?

The IUPAC name of 3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine (CID 158428423) is 3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine.

What is the SMILES notation for 3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine?

The canonical SMILES for 3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine is CC(NC(=O)c1nc2ccccc2nc1N)c1ccccc1.CN(C)c1cccc(CNC(=O)c2nc3ccccc3nc2N)c1.Cc1ccc(-c2nnc(-c3nc4ccccc4nc3N)o2)cc1.Cc1cccc(CNC(=O)c2nc3ccccc3nc2N)c1.Cc1cccc(CNC(=O)c2nc3ccccc3nc2N)c1.Cc1nnc(-c2nc3ccccc3nc2N)o1.Cc1nnc(-c2nc3ccccc3nc2N)o1.Nc1ccccc1-c1nnc(-c2nc3ccccc3nc2N)o1.Nc1nc2ccccc2nc1-c1nnc(-c2cccnc2)o1.Nc1nc2ccccc2nc1C(=O)NCc1ccccc1.

What is the InChIKey of 3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine?

The InChIKey is HBIPZWPVLIKFGT-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H19N5O.C17H13N5O.3C17H16N4O.C16H12N6O.C16H14N4O.C15H10N6O.2C11H9N5O/c1-23(2)13-7-5-6-12(10-13)11-20-18(24)16-17(19)22-15-9-4-3-8-14(15)21-16;1-10-6-8-11(9-7-10)16-21-22-17(23-16)14-15(18)20-13-5-3-2-4-12(13)19-14;2*1-11-5-4-6-12(9-11)10-19-17(22)15-16(18)21-14-8-3-2-7-13(14)20-15;1-11(12-7-3-2-4-8-12)19-17(22)15-16(18)21-14-10-6-5-9-13(14)20-15;17-10-6-2-1-5-9(10)15-21-22-16(23-15)13-14(18)20-12-8-4-3-7-11(12)19-13;17-15-14(19-12-8-4-5-9-13(12)20-15)16(21)18-10-11-6-2-1-3-7-11;16-13-12(18-10-5-1-2-6-11(10)19-13)15-21-20-14(22-15)9-4-3-7-17-8-9;2*1-6-15-16-11(17-6)9-10(12)14-8-5-3-2-4-7(8)13-9/h3-10H,11H2,1-2H3,(H2,19,22)(H,20,24);2-9H,1H3,(H2,18,20);2*2-9H,10H2,1H3,(H2,18,21)(H,19,22);2-11H,1H3,(H2,18,21)(H,19,22);1-8H,17H2,(H2,18,20);1-9H,10H2,(H2,17,20)(H,18,21);1-8H,(H2,16,19);2*2-5H,1H3,(H2,12,14).

What are the key properties of 3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine?

3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine has a molecular weight of 2829.10 g/mol, XLogP of 23.17, 24 rotatable bonds, 16 hydrogen bond donors, and 53 hydrogen bond acceptors.

Where does this data come from?

All data for 3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine is sourced from PubChem (CID 158428423), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).